Similar Items: Prostatic fibroblast reprogramming by Interleukin-30 activates prostate cancer metastasis programs
- Characterising the mechanism of DCUN1D1 activity in prostate cancer and identifying DCUN1D1 inhibitors for prostate cancer treatment
- Correction to “Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients”
- Identification of genetically predicted protein biomarkers and drug targets for prostate cancer via Mendelian randomization
- Molecular Evaluation of Interleukin-8, Interleukin-27, and Vascular Endothelial Growth Factor Expression in Prostate Cancer Patients
- Metabolic reprograming and cancer resistance : an investigation into the metabolic control of cancer-associated fibroblasts on breast cancer cell survival and metastasis
- Prostate cancer diagnosis using plasma extracellular vesicles isolated via aqueous two‐phase systems